Sponsor content
108 result(s) found, displaying 31 to 40
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Interpretive software IVDs.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Inborn/inherited genetic disorder IVDs.
-
Australian public assessment report (AusPar)AusPAR for Xembify (human normal immunoglobulin) for the treatment of primary immunodeficiency diseases.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Fluid transfer set, general-purpose.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Intravenous fluid container, single use.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Immunohaematology calibrator/control IVDs.
-
Prescription medicine decision summaryTGA decision: Xembify (normal immunoglobulin human) is approved to treat primary immunodeficiency diseases (PID).
-
Australian public assessment report (AusPar)VeraSeal (human fibrinogen and human thrombin) for the supportive treatment of hemostasis.
-
Prescription medicine registrationActive ingredients: human immunoglobulin G.
-
Prescription medicine decision summaryTGA decision: VeraSeal (human fibrinogen/ human thrombin) is approved to treat hemostasis.